摘要
ObjectiveTo investigate the hepatoprotective efficacy of cranberry extract (CBE) against carbon tetrachloride (CCl<sub>4</sub>)-induced hepatic injury using in-vivo animal model.MethodsThe hepatoprotective efficacy of CBE (200 and 400 mg/kg) was investigated against CCl<sub>4</sub> (4 mL/kg)-induced hepatotoxicity, elevated liver enzymes [ALT (alanine aminotransferase), AST (aspartate aminotransferase), and alkaline phosphatase (ALP)], and total protein (TP) contents in the serum. Moreover, CBE-aided antioxidant defense against hepatotoxic insult of CCl<sub>4</sub> was measured by evaluating a number of anti-oxidative biomarkers including reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), and malondialdehyde (MDA) in the serum by using spectrophotometric analyses.ResultsResults showed that the exposure of experimental animals to CCl<sub>4</sub> did induce significant hepatotoxicity compared to the non-induced (untreated) group. The oral administration of CBE demonstrated a significant dose-dependent alleviation in the liver enzymes (AST, ALT, and ALP), increased antioxidant defense (GSH, SOD, and CAT), and reduced MDA levels in the serum of treated animals compared to the animals without treatment. The resulting data showed that the administration of CBE decreased the serum levels of ALT, AST, and ALP compared to the CCl<sub>4</sub>-induced group.ConclusionsThe resulting data evidenced that CBE exhibits promising hepatoprotective potential against the chemical induced hepatotoxicity, maintains homeostasis in liver enzymes, and can provide significant antioxidant defense against free radicals-induced oxidative stress.
Objective: To investigate the hepatoprotective efficacy of cranberry extract(CBE)against carbon tetrachloride(CCl4)-induced hepatic injury using in-vivo animal model.Methods: The hepatoprotective efficacy of CBE(200 and 400 mg/kg) was investigated against CCl4(4 m L/kg)-induced hepatotoxicity, elevated liver enzymes [ALT(alanine aminotransferase), AST(aspartate aminotransferase), and alkaline phosphatase(ALP)],and total protein(TP) contents in the serum. Moreover, CBE-aided antioxidant defense against hepatotoxic insult of CCl4 was measured by evaluating a number of anti-oxidative biomarkers including reduced glutathione(GSH), superoxide dismutase(SOD), catalase(CAT), and malondialdehyde(MDA) in the serum by using spectrophotometric analyses.Results: Results showed that the exposure of experimental animals to CCl4 did induce significant hepatotoxicity compared to the non-induced(untreated) group. The oral administration of CBE demonstrated a significant dose-dependent alleviation in the liver enzymes(AST, ALT, and ALP), increased antioxidant defense(GSH, SOD, and CAT),and reduced MDA levels in the serum of treated animals compared to the animals without treatment. The resulting data showed that the administration of CBE decreased the serum levels of ALT, AST, and ALP compared to the CCl4-induced group.Conclusions: The resulting data evidenced that CBE exhibits promising hepatoprotective potential against the chemical induced hepatotoxicity, maintains homeostasis in liver enzymes, and can provide significant antioxidant defense against free radicals-induced oxidative stress.
基金
the Institute of Molecular Biology and Biotechnology (IMBB), University of Lahore for providing resources and financial support
